Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma Ads (NQ: ASND )

160.26 USD -0.40 (-0.25%)
Streaming Delayed Price Updated: 1:49 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108,597
Open 161.00
Bid (Size) 159.72 (2)
Ask (Size) 160.52 (1)
Prev. Close 160.66
Today's Range 157.05 - 162.21
52wk Range 92.00 - 183.98
Shares Outstanding 41,779,122
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China, announced today the... 
From PR Newswire

Performance

YTD
-3.16%
-3.16%
1 Month
-5.63%
-5.63%
3 Month
+1.04%
+1.04%
6 Month
+14.74%
+14.74%
1 Year
+17.81%
+17.81%

More News

Read More
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
From GlobeNewswire News Releases
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
From PR Newswire
Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Planned Board Transition
From GlobeNewswire News Releases
Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
From GlobeNewswire News Releases
Ascendis Pharma A/S to Host Virtual Oncology R&D Day on Friday, November 20
From GlobeNewswire News Releases
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
From ChinaBio® Today
Week In Review: BeiGene Signs $2.2 Billion Deal With Novartis For PD-1
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.